Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Triple-negative breast cancer (TNBC) is a particularly aggressive form of breast cancer, accounting for 15-20% of all breast cancer cases. Known for its poor prognosis and lack of effective treatment options, TNBC presents a significant challenge in oncology. However, recent advancements in spatial
The recent research focusing on the safety of anti-seizure medications during pregnancy provides new insights that are crucial for expectant mothers. The study, led by Stanford Medicine and published in JAMA Neurology, evaluates the long-term effects of lamotrigine and levetiracetam on children
Gastroesophageal reflux disease (GERD) is a common condition characterized by chronic symptoms such as heartburn resulting from the regurgitation of stomach contents. If left untreated, GERD can lead to Barrett’s esophagus, a condition where the lining of the lower esophagus changes, increasing the
Recent research has shed light on the alarming connection between cardiovascular risks, obesity, and accelerated brain aging. This study delves into how these factors contribute to neurodegeneration, especially Alzheimer's disease, and reveals significant findings about the differential impact
